Research Institute
Filter News
Found 2,563 articles
-
Phase III study shows quizartinib prolongs overall survival for patients with deadly type of relapsed or refractory AML
6/18/2018
A study led by The University of Texas MD Anderson Cancer Center revealed that the investigational drug quizartinib prolonged overall survival for patients with a deadly form of acute myeloid leukemia (AML).
-
From CRISPR to spider silk there are some great scientific research stories out this week.
-
TRC Healthcare Partners With athenahealth To Provide Access To Prescriber's Letter Excerpts Through The Epocrates Mobile App
6/14/2018
The #1 Medical App for Clinicians Will Offer Complimentary Access to Newsworthy Clinical Findings and Evidence-Based Drug Therapy Recommendations
-
Latest bioelectronic medicine discoveries focus of Feinstein Institute-hosted symposium
6/14/2018
The Feinstein Institute for Medical Research, the Karolinska Institutet and its journal, the Journal of Internal Medicine, hosted "Bioelectronic Medicine: Technology Targeting Molecular Mechanisms," which took place June 12-14 in Stockholm, Sweden.
-
Kalorama Information: EHR Industry Anticipates Innovations from Entry of Google, Microsoft, Amazon
6/14/2018
undreds of patents, a secret project with a number for a name, machine learning to prevent heart attacks. Even high-tech spoons for patients.
-
OTC Markets Group Welcomes The Green Organic Dutchman Holdings Ltd. to OTCQX
6/14/2018
OTC Markets Group Inc. announced The Green Organic Dutchman Holdings Ltd. has qualified to trade on the OTCQX® Best Market.
-
Deloitte, NIH: Two Student-led Research Teams Recognized for Discoveries in DNA Data, Advance Understanding of New Viruses, Antibiotic Resistance
6/14/2018
With prize money, access to DNA datasets and the opportunity to study DNA data, teams from San Diego State University and The City University of New York/Kingsborough Community College compete in the Microbial Metagenomics Discovery Challenge, make significant scientific discoveries
-
Pure Encapsulations® launches PureResponse™, first-to-market platform to support conditions related to healthy immune balance and function
6/14/2018
BOSTON, June 14, 2018 /PRNewswire/ -- Pure Encapsulations®, a leading manufacturer of research-based, hypoallergenic nutritional supplements, has launched PureResponseTM, a first-of-its-kind platform at the forefront of functional immunology.
-
Now, two studies published in Nature Medicine suggest that CRISPR may lead to cancer unintentionally.
-
Surgical Staplers to Witness Wide Adoption in India
6/13/2018
The popularity of surgical staplers has successfully grown in India, as they are being gradually used as an alternative to the traditional surgical method of suturing.
-
Five Corners joins Factory CRO
6/12/2018
Factory CRO, has announced that Five Corners is joining Factory CRO.
-
Medpace Holdings, Inc. Announces Pricing of Secondary Offering of 3,000,000 Shares of Common Stock by Selling Shareholder
6/12/2018
Medpace Holdings, Inc. announced the pricing of the previously announced secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $42.25 per share.
-
US Dermatologists Report Significant Growth of Next-Generation Psoriasis Biologics--Novartis' Cosentyx, Eli Lilly's Taltz, and Janssen's Tremfya
6/12/2018
Growth of the IL-17 inhibitors and Tremfya has been at the expense of the established TNF inhibitors and Janssen's own Stelara.
-
GenScript Supports the Development of a Novel HIV Vaccine
6/12/2018
A promising experimental HIV vaccine was reported in Nature Medicine on June 4, 2018 by Kai Xu and colleagues from Drs. Mascola and Kwong labs at the Vaccine Research Center (VRC)
-
Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology
6/12/2018
Shanghai ChemPartner announced the appointment of Ming Liu, Ph.D. as Vice President and the Head of Biology and Pharmacology at the company headquarters in Shanghai, China.
-
CHUM Develops Distinctive Immunotherapy Program - Treating Cancer with the Patient's Own Immune Cells
6/12/2018
CHUM (Centre hospitalier de l'Université de Montréal) and CRCHUM (its research centre) are now working on a pioneering cancer immunotherapy that employs immune cell infusion. This ground-breaking, personalized approach treats patients using cells taken from their own tumours.
-
U.S. Food and Drug Administration Clears Wearable Device to Treat Opioid Addiction
6/12/2018
DyAnsys Inc. announced that the U.S. Food and Drug Administration has cleared its auricular neurostimulation device, Drug Relief®, to be used as an aid to reduce the symptoms of opioid withdrawal without narcotics.
-
Synlogic Presents Preclinical Data from Synthetic BioticTM Medicine, SYNB1618, for the Treatment of Phenylketonuria
6/11/2018
Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage drug discovery and development company applying synthetic biology to probiotics to develop novel living medicines, today announced the presentation of preclinical data from SYNB1618, an investigational Synthetic Biotic medicine currently being evaluated in an ongoing Phase 1/2a clinical trial in healthy volunteers and patients with PKU.
-
IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness
6/11/2018
IQVIA Inc. announced that it has placed approximately $1.65 billion of USD and EUR term B loans
-
Medpace Holdings, Inc. Announces Secondary Offering of 3,000,000 Shares Common Stock by Selling Shareholder
6/11/2018
Medpace Holdings, Inc. announced a secondary offering of 3,000,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited